Can a gentle brain current halt stubborn seizures?
NCT ID NCT06344338
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This trial tests whether targeted transcranial direct current stimulation (tDCS) can help stop refractory status epilepticus — a life-threatening condition where seizures don't stop with standard drugs. About 32 people aged 14 to 80 with this condition will receive either real tDCS or a sham (inactive) version, with up to 10 sessions. The goal is to see if the real stimulation safely helps end the seizures, as measured by brain activity and clinical observation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- targeted transcranial direct current stimulation (tDCS) — a non-invasive brain stimulation device
- What this could lead to
- If effective, tDCS could offer a non-drug option to help stop prolonged seizures that don't respond to standard treatments.
- What could go wrong
- This is a small early-stage trial, and the effect is uncertain. tDCS may not stop seizures in all patients, and there is a risk of treatment-related side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY STATUS EPILEPTICUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xuanwu Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100053, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.